Page last updated: 2024-11-05

triazolam and Anxiety Neuroses

triazolam has been researched along with Anxiety Neuroses in 8 studies

Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Research Excerpts

ExcerptRelevanceReference
"The authors report a case of a 55-year-old man undergoing a triazolam withdrawal syndrome that was recognized and treated with high doses of benzodiazepines, but the patient nevertheless developed seizures."7.67Seizures following triazolam withdrawal despite benzodiazepine treatment. ( Pawluczyk, S; Schneider, LS; Syapin, PJ, 1987)
"The authors report a case of a 55-year-old man undergoing a triazolam withdrawal syndrome that was recognized and treated with high doses of benzodiazepines, but the patient nevertheless developed seizures."3.67Seizures following triazolam withdrawal despite benzodiazepine treatment. ( Pawluczyk, S; Schneider, LS; Syapin, PJ, 1987)
"Triazolam-treated patients presented significantly more day-time-interdose anxiety than zopiclone as assessed by the weekly HARS and Clinical Global Assessment of Anxiety."2.67Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety. ( Beauclair, L; Beaudry, P; Chouinard, G; Fontaine, R; Le Morvan, P, 1990)
"The study subjects were chronic insomniacs with moderate levels of psychopathology and prior use of hypnotics."2.66Profile of mood states changes during and after 5 weeks of nightly triazolam administration. ( Bliwise, DL; Bliwise, NG; Cohen, SA; Dement, WC; Seidel, WF, 1988)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19905 (62.50)18.7374
1990's1 (12.50)18.2507
2000's0 (0.00)29.6817
2010's1 (12.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Shadli, SM2
High, O1
Byers, B1
Gibbs, P1
Steller, R1
Glue, P2
McNaughton, N2
McIntosh, J1
Morgan, K1
Oswald, I1
Fontaine, R1
Beaudry, P1
Le Morvan, P1
Beauclair, L1
Chouinard, G1
Moon, CA1
Ankier, SI1
Hayes, G1
Schneider, LS1
Syapin, PJ1
Pawluczyk, S1
Bliwise, DL1
Seidel, WF1
Cohen, SA1
Bliwise, NG1
Dement, WC1

Trials

5 trials available for triazolam and Anxiety Neuroses

ArticleYear
Human anxiety-specific "theta" occurs with selective stopping and localizes to right inferior frontal gyrus.
    Behavioral neuroscience, 2020, Volume: 134, Issue:6

    Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Biomarkers; Buspirone; Electroencephalogr

2020
Anxiety caused by a short-life hypnotic.
    British medical journal (Clinical research ed.), 1982, Mar-27, Volume: 284, Issue:6320

    Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Clinical Trials as Topic

1982
Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety.
    International clinical psychopharmacology, 1990, Volume: 5, Issue:3

    Topics: Adult; Anxiety Disorders; Azabicyclo Compounds; Drug Administration Schedule; Female; Humans; Hypnot

1990
Early morning insomnia and daytime anxiety--a multicentre general practice study comparing loprazolam and triazolam.
    The British journal of clinical practice, 1985, Volume: 39, Issue:9

    Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Benzodiazepinones;

1985
Profile of mood states changes during and after 5 weeks of nightly triazolam administration.
    The Journal of clinical psychiatry, 1988, Volume: 49, Issue:9

    Topics: Adult; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; MMPI;

1988

Other Studies

3 other studies available for triazolam and Anxiety Neuroses

ArticleYear
An improved human anxiety process biomarker: characterization of frequency band, personality and pharmacology.
    Translational psychiatry, 2015, Dec-15, Volume: 5

    Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Biomarkers; Brain; Buspirone; Electroence

2015
Anxiety caused by a short-life hypnotic.
    British medical journal (Clinical research ed.), 1982, Jun-12, Volume: 284, Issue:6331

    Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Half-Life; Humans; Triaz

1982
Seizures following triazolam withdrawal despite benzodiazepine treatment.
    The Journal of clinical psychiatry, 1987, Volume: 48, Issue:10

    Topics: Anti-Anxiety Agents; Anxiety Disorders; Chlordiazepoxide; Diazepam; Humans; Male; Middle Aged; Recep

1987